Cytotron Treatment in Malaysia, Hong Kong, UAE and Mexico
Cancer is the second leading cause of death globally which is responsible for over nine million deaths in 2018. The treatment depends on the stage of this disease in which abnormal cells divide uncontrollably and destroy body tissue. Recently an Indian scientist, Rajah Vijay Kumar, based in Bangalore, made an unbelievable device, which is being called a 'breakthrough device' in cancer care by the Food and Drug Administration's (FDA) Centre for Device and Radiological Health, US.
Having this 'breakthrough device' designation means that there is evidence that the drug or therapy that treats a serious condition, in this case, a device, demonstrates “substantial improvement on a clinically significant endpoint(s) over available therapies.” With it, the review and development of the treatment will be expedited so that it will be available as soon as it can be concluded that the benefits justify the risks, considering the seriousness of the disease as well as the availability of other treatments.
The Indian scientist created this device at the Centre for Advanced Research and Development in Bhopal. As per the reports this medical invention, 'Cytotron,' works as a supporting element in the tissue engineering of cancer cells by altering how specific proteins are regulated to stop the affected cells from multiplying and spreading.
This device uses fast radio bursts (FRB), high energy and powerful short radio bursts in which both magnetic and electric elements of the electromagnetic signals are circularly polarised. The one and only aim of this device is to reduce the uncontrolled growth of affected cancerous tissues.
It should be noted Kumar did not have to import any parts to create this device, which was praised by the FDA, as it is set to be produced in India itself. However, the Centre for Device and Radiological Health is responsible for the premarket approval of 'Cytotron,' in the US. It has already been approved and currently, in countries like UAE, Mexico, Malaysia and Hong Kong, medical experts are using 'Cytotron,' to treat cancer.
"It is a great feeling that after so many years of hard work, against all odds, an institution like the USFDA is designating our work as a breakthrough in the treatment of three types of cancers," which are liver, pancreatic and breast cancer, said Kumar.
How Cytotron Works?
Cytotron, which Kumar developed after 30 years of research, uses fast radio bursts (FRB) to communicate with cellular command and control to regulate a specific gene or protein. Specifically, Cytotron first alters the protein pathways of a protein called P53 to induce death in cancer cells, then it stops the spread of cancer by inhibiting the epithelial-mesenchymal transition cells responsible for the spread of cancer.
Generically known as Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR), it is a technology that is made to deliver highly complex quantum instantaneous Nuclear Magnetic Resonance beams in the RF bands and its harmonics ranging from 3KHz to 300 MHz with a near field delivery using specialized antenna in the presence of high instantaneous magnetic field.
Simply put, Cytotron is specifically designed to cause the death of cancer cells and to stop it from spreading, features that are very important considering that a significant percentage of cancer patients die from metastasis or the spread of cancer.
References:
 |
| Image: Wikipedia |
Having this 'breakthrough device' designation means that there is evidence that the drug or therapy that treats a serious condition, in this case, a device, demonstrates “substantial improvement on a clinically significant endpoint(s) over available therapies.” With it, the review and development of the treatment will be expedited so that it will be available as soon as it can be concluded that the benefits justify the risks, considering the seriousness of the disease as well as the availability of other treatments.
The Indian scientist created this device at the Centre for Advanced Research and Development in Bhopal. As per the reports this medical invention, 'Cytotron,' works as a supporting element in the tissue engineering of cancer cells by altering how specific proteins are regulated to stop the affected cells from multiplying and spreading.
This device uses fast radio bursts (FRB), high energy and powerful short radio bursts in which both magnetic and electric elements of the electromagnetic signals are circularly polarised. The one and only aim of this device is to reduce the uncontrolled growth of affected cancerous tissues.
It should be noted Kumar did not have to import any parts to create this device, which was praised by the FDA, as it is set to be produced in India itself. However, the Centre for Device and Radiological Health is responsible for the premarket approval of 'Cytotron,' in the US. It has already been approved and currently, in countries like UAE, Mexico, Malaysia and Hong Kong, medical experts are using 'Cytotron,' to treat cancer.
"It is a great feeling that after so many years of hard work, against all odds, an institution like the USFDA is designating our work as a breakthrough in the treatment of three types of cancers," which are liver, pancreatic and breast cancer, said Kumar.
How Cytotron Works?
Cytotron, which Kumar developed after 30 years of research, uses fast radio bursts (FRB) to communicate with cellular command and control to regulate a specific gene or protein. Specifically, Cytotron first alters the protein pathways of a protein called P53 to induce death in cancer cells, then it stops the spread of cancer by inhibiting the epithelial-mesenchymal transition cells responsible for the spread of cancer.
Generically known as Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR), it is a technology that is made to deliver highly complex quantum instantaneous Nuclear Magnetic Resonance beams in the RF bands and its harmonics ranging from 3KHz to 300 MHz with a near field delivery using specialized antenna in the presence of high instantaneous magnetic field.
Simply put, Cytotron is specifically designed to cause the death of cancer cells and to stop it from spreading, features that are very important considering that a significant percentage of cancer patients die from metastasis or the spread of cancer.
Cancer Treatments
Different cancers require different treatments, but the treatment a patient is given may also vary depending on the size or progression of cancer. In some cases, a patient may undergo just one type of treatment, but others may require a combination of two or more. Some patients may also opt to participate in clinical trials for new possible treatments.
While the ultimate goal of cancer treatments is to free patients from their cancer and allow them to live a normal life span, in some severe cases, the goal may simply be to slow the growth of cancer and allow the patients to live symptom-free for as long as possible.
Different cancers require different treatments, but the treatment a patient is given may also vary depending on the size or progression of cancer. In some cases, a patient may undergo just one type of treatment, but others may require a combination of two or more. Some patients may also opt to participate in clinical trials for new possible treatments.
While the ultimate goal of cancer treatments is to free patients from their cancer and allow them to live a normal life span, in some severe cases, the goal may simply be to slow the growth of cancer and allow the patients to live symptom-free for as long as possible.
References:
Comments